menu
European Commission
This project has received funding from the
European Union’s Seventh Framework Programme
for research, technological development and demonstration.
agence de communication Lyon
menu

    TumAdoR PROJECT

    Developing New Therapeutic Monoclonal Antibodies to neutralize Adenosine immunosuppressive pathway in tumour context

    Based on the broad immuno-suppression and strong tumour promotion (proliferation and dissemination) exerted by Adenosine, therapeutic strategies aimed at inhibiting Adenosine are highly promising

    Events
    News

    17 January 2017 Meeting of Pathologists in Lausanne

    WP2 IHC subgroup exceptionnal meetingMore >>


    17 January 2017 M42 meeting in Diablerets

    LICR Partner proposed to organized the coming M42 meeting in the region of Lausanne for a change. Partners will meet on 10th and 11th of March in Diablerets.More >>


    Displaying results 1 to 2 out of 7
    Brochure